Merck signs deal to develop biologic conjugates
03:27 EDT 19 Jun 2012 | SmartBrief
Ambrx and Merck agreed to jointly design and develop biologic drug conjugates using the former's site-specific protein medici -More-
Original Article: Merck signs deal to develop biologic conjugates
More From BioPortfolio on "Merck signs deal to develop biologic conjugates"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
